Medincell SA (MEDCL) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.465x

Based on the latest financial reports, Medincell SA (MEDCL) has a cash flow conversion efficiency ratio of 0.465x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-14.25 Million ≈ $-16.66 Million USD) by net assets (€-30.63 Million ≈ $-35.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medincell SA - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Medincell SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MEDCL total debt and obligations for a breakdown of total debt and financial obligations.

Medincell SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medincell SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
KPI Green Energy Limited NSE:KPIGREEN	0.007x
Jiangsu Olive Sensors High-Tech Co Ltd SHE:300507	-0.025x
BioLife Solutions Inc NASDAQ:BLFS	0.013x
Allianz Malaysia Bhd KLSE:1163	0.024x
Zhejiang Dehong Automotive SHG:603701	-0.014x
Australian United Investment Company Ltd AU:AUI	0.039x
China CYTS Tours Holding Co Ltd SHG:600138	0.044x
Shenzhen Tellus Holding Co Ltd SHE:000025	0.009x

Annual Cash Flow Conversion Efficiency for Medincell SA (2016–2025)

The table below shows the annual cash flow conversion efficiency of Medincell SA from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Medincell SA (MEDCL) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	€-16.37 Million ≈ $-19.13 Million	€19.46 Million ≈ $22.76 Million	-1.189x	-507.24%
2024-03-31	€-40.82 Million ≈ $-47.73 Million	€-11.92 Million ≈ $-13.94 Million	0.292x	-41.20%
2023-03-31	€-42.29 Million ≈ $-49.45 Million	€-21.00 Million ≈ $-24.56 Million	0.497x	-68.91%
2022-03-31	€-13.37 Million ≈ $-15.63 Million	€-21.36 Million ≈ $-24.97 Million	1.598x	+217.37%
2021-03-31	€8.92 Million ≈ $10.42 Million	€-12.14 Million ≈ $-14.19 Million	-1.361x	-273.23%
2020-03-31	€-15.96 Million ≈ $-18.66 Million	€-12.54 Million ≈ $-14.66 Million	0.786x	+130.79%
2019-03-31	€6.24 Million ≈ $7.30 Million	€-15.93 Million ≈ $-18.63 Million	-2.552x	-652.58%
2018-03-31	€-11.75 Million ≈ $-13.74 Million	€-5.43 Million ≈ $-6.34 Million	0.462x	-68.86%
2017-03-31	€-2.29 Million ≈ $-2.67 Million	€-3.39 Million ≈ $-3.97 Million	1.483x	+2787.40%
2016-03-31	€1.32 Million ≈ $1.55 Million	€68.00K ≈ $79.50K	0.051x	--

About Medincell SA

PA:MEDCL France Biotechnology

Market Cap

$955.80 Million

€817.55 Million EUR

Market Cap Rank

#9303 Global

#145 in France

Share Price

€24.68

Change (1 day)

-0.56%

52-Week Range

€14.93 - €38.46

All Time High

€38.46